Literature DB >> 34034663

Secretome characterization of clinical isolates from the Mycobacterium abscessus complex provides insight into antigenic differences.

Florian P Maurer1,2,3, Adrian Ochoa-Leyva4, Fernanda Cornejo-Granados5, Thomas A Kohl6,7, Flor Vásquez Sotomayor8, Sönke Andres8, Rogelio Hernández-Pando9, Juan Manuel Hurtado-Ramirez5, Christian Utpatel6,7, Stefan Niemann6,7.   

Abstract

BACKGROUND: Mycobacterium abscessus (MAB) is a widely disseminated pathogenic non-tuberculous mycobacterium (NTM). Like with the M. tuberculosis complex (MTBC), excreted / secreted (ES) proteins play an essential role for its virulence and survival inside the host. Here, we used a robust bioinformatics pipeline to predict the secretome of the M. abscessus ATCC 19977 reference strain and 15 clinical isolates belonging to all three MAB subspecies, M. abscessus subsp. abscessus, M. abscessus subsp. bolletii, and M. abscessus subsp. massiliense.
RESULTS: We found that ~ 18% of the proteins encoded in the MAB genomes were predicted as secreted and that the three MAB subspecies shared > 85% of the predicted secretomes. MAB isolates with a rough (R) colony morphotype showed larger predicted secretomes than isolates with a smooth (S) morphotype. Additionally, proteins exclusive to the secretomes of MAB R variants had higher antigenic densities than those exclusive to S variants, independent of the subspecies. For all investigated isolates, ES proteins had a significantly higher antigenic density than non-ES proteins. We identified 337 MAB ES proteins with homologues in previously investigated M. tuberculosis secretomes. Among these, 222 have previous experimental support of secretion, and some proteins showed homology with protein drug targets reported in the DrugBank database. The predicted MAB secretomes showed a higher abundance of proteins related to quorum-sensing and Mce domains as compared to MTBC indicating the importance of these pathways for MAB pathogenicity and virulence. Comparison of the predicted secretome of M. abscessus ATCC 19977 with the list of essential genes revealed that 99 secreted proteins corresponded to essential proteins required for in vitro growth.
CONCLUSIONS: This study represents the first systematic prediction and in silico characterization of the MAB secretome. Our study demonstrates that bioinformatics strategies can help to broadly explore mycobacterial secretomes including those of clinical isolates and to tailor subsequent, complex and time-consuming experimental approaches accordingly. This approach can support systematic investigation exploring candidate proteins for new vaccines and diagnostic markers to distinguish between colonization and infection. All predicted secretomes were deposited in the Secret-AAR web-server ( http://microbiomics.ibt.unam.mx/tools/aar/index.php ).

Entities:  

Keywords:  Antigenicity; Bioinformatics; In silico analysis; M. abscessus subspecies; Vaccinology

Mesh:

Year:  2021        PMID: 34034663     DOI: 10.1186/s12864-021-07670-7

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


  31 in total

1.  Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.

Authors:  M Sanguinetti; F Ardito; E Fiscarelli; M La Sorda ; P D'Argenio; G Ricciotti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Mycobacterium abscessus: a new antibiotic nightmare.

Authors:  Rachid Nessar; Emmanuelle Cambau; Jean Marc Reyrat; Alan Murray; Brigitte Gicquel
Journal:  J Antimicrob Chemother       Date:  2012-01-30       Impact factor: 5.790

3.  Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.

Authors:  Julie Jarand; Adrah Levin; Lening Zhang; Gwen Huitt; John D Mitchell; Charles L Daley
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

4.  Secreted antigens of Mycobacterium tuberculosis: characterization with T lymphocytes from patients and contacts after two-dimensional separation.

Authors:  S Daugelat; H Gulle; B Schoel; S H Kaufmann
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

5.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

6.  Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. nov.

Authors:  Enrico Tortoli; Thomas A Kohl; Barbara A Brown-Elliott; Alberto Trovato; Sylvia Cardoso Leão; Maria Jesus Garcia; Sruthi Vasireddy; Christine Y Turenne; David E Griffith; Julie V Philley; Rossella Baldan; Silvia Campana; Lisa Cariani; Carla Colombo; Giovanni Taccetti; Antonio Teri; Stefan Niemann; Richard J Wallace; Daniela M Cirillo
Journal:  Int J Syst Evol Microbiol       Date:  2016-08-04       Impact factor: 2.747

Review 7.  Proteomics of protein secretion by Bacillus subtilis: separating the "secrets" of the secretome.

Authors:  Harold Tjalsma; Haike Antelmann; Jan D H Jongbloed; Peter G Braun; Elise Darmon; Ronald Dorenbos; Jean-Yves F Dubois; Helga Westers; Geeske Zanen; Wim J Quax; Oscar P Kuipers; Sierd Bron; Michael Hecker; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 8.  Molecular bases and role of viruses in the human microbiome.

Authors:  Shira R Abeles; David T Pride
Journal:  J Mol Biol       Date:  2014-07-11       Impact factor: 5.469

9.  Mycobacterium abscessus Complex Infections in Humans.

Authors:  Meng-Rui Lee; Wang-Huei Sheng; Chien-Ching Hung; Chong-Jen Yu; Li-Na Lee; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

10.  Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease.

Authors:  Jianhui Chen; Lan Zhao; Yanhua Mao; Meiping Ye; Qi Guo; Yongjie Zhang; Liyun Xu; Zhemin Zhang; Bing Li; Haiqing Chu
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.